Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

8.38

+0.14 (1.70%)

At close: Jul 29, 2026, 4:00 PM EDT

8.39

+0.01 (0.12%)

After-hours: Jul 29, 2026, 7:34 PM EDT

Xeris Biopharma Holdings Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	314.85	291.85	203.07	163.91	110.25	49.59
Revenue Growth	41.48%	43.72%	23.89%	48.68%	122.32%	142.67%
Gross Profit	270.44	249.28	166.24	135.27	87.61	36.27
Operating Income	35.9	24.9	-33.65	-44.01	-81.94	-115.16
Net Income	12.01	0.55	-54.84	-62.26	-94.66	-122.73
Earnings Per Share	0.06	0.00	-0.37	-0.45	-0.70	-1.55
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	111.75	111.04	71.62	72.45	121.97	102.43
Total Debt	258.55	258.1	271.45	229.19	198.06	88.07
Net Cash (Debt)	-146.8	-147.06	-199.83	-156.74	-76.09	14.37
Net Cash Growth	-	-	-	-	-	-69.28%
Net Cash Per Share	-0.85	-0.85	-1.36	-1.14	-0.56	0.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	48.53	28.63	-36.98	-47.02	-102.89	-95.54
Capital Expenditures	-1.01	-0.7	-0.87	-2.26	-0.52	-1.09
Free Cash Flow	47.52	27.93	-37.85	-49.29	-103.42	-96.62
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	85.89%	85.41%	81.86%	82.52%	79.47%	73.14%
Operating Margin	11.40%	8.53%	-16.57%	-26.85%	-74.32%	-232.22%
Pretax Margin	3.81%	0.19%	-28.12%	-38.74%	-87.15%	-247.48%
Profit Margin	3.81%	0.19%	-27.00%	-37.98%	-85.86%	-247.48%
FCF Margin	15.09%	9.57%	-18.64%	-30.07%	-93.80%	-194.84%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	130.73	2447.71	-	-	-	-
Forward PE	68.86	64.50	-	-	-	-
P/FCF Ratio	31.96	46.72	-	-	-	-
PS Ratio	4.82	4.47	2.49	1.98	1.64	7.38